Matches in SemOpenAlex for { <https://semopenalex.org/work/W2497114778> ?p ?o ?g. }
- W2497114778 endingPage "261" @default.
- W2497114778 startingPage "261" @default.
- W2497114778 abstract "Objective The identification of cancer stem-like cells is a recent development in ovarian cancer. Compared to other cancer cells, cancer stem-like cells present more chemo-resistance and more aggressive characteristics. They play an important role in the recurrence and drug resistance of cancer. Therefore, the target therapy of cancer stem-like cell may become a promising and effective approach for ovarian cancer treatment. It may also help to provide novel diagnostic and therapeutic strategies. Methods The OVCAR3 cell line was cultured under serum-free conditions to produce floating spheres. The CD44+CD117+ cell line was isolated from the human ovarian cancer cell line OVCAR3 by using immune magnetic-activated cell sorting system. The expression of stemness genes such as OCT3/4, NANOG and SOX2 mRNA were determined by reverse transcription polymerase chain reaction. OVCAR3 parental and OVCAR3 CD44+CD117+ cells were grown in different doses of paclitaxel and salinomycin to evaluate the effect of salinomycin. And growth inhibition of OVCAR3 CD44+CD117+ cells by paclitaxel combined with salinomycin was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Results Tumor spheroids generated from the OVCAR3 cell line are shown to have highly enriched CD44 and CD117 expression. Treatment with a combination of paclitaxel and salinomycin demonstrated growth inhibition of OVCAR3 CD44+CD117+ cells. Conclusion The present study is a detailed investigation on the expression of CD44 and CD117 in cancer stem cells and evaluates their specific tumorigenic characteristics in ovarian cancer. This study also demonstrates significant growth inhibition of cancer stem-like cells by paclitaxel combined with salinomycin. Identification of these cancer stem-like cell markers and growth inhibition effect of salinomycin may be the next step to the development of novel target therapy in ovarian cancer. Keywords: Ovarian neoplasms; Salinomycin; Stem-like cell" @default.
- W2497114778 created "2016-08-23" @default.
- W2497114778 creator A5002541135 @default.
- W2497114778 creator A5021475520 @default.
- W2497114778 creator A5075968961 @default.
- W2497114778 creator A5077805782 @default.
- W2497114778 creator A5079807358 @default.
- W2497114778 creator A5081845574 @default.
- W2497114778 creator A5084956582 @default.
- W2497114778 date "2016-01-01" @default.
- W2497114778 modified "2023-09-30" @default.
- W2497114778 title "The effect of salinomycin on ovarian cancer stem-like cells" @default.
- W2497114778 cites W1438292419 @default.
- W2497114778 cites W1756841812 @default.
- W2497114778 cites W1966354133 @default.
- W2497114778 cites W1992514491 @default.
- W2497114778 cites W2006307101 @default.
- W2497114778 cites W2008893427 @default.
- W2497114778 cites W2019865561 @default.
- W2497114778 cites W2032986953 @default.
- W2497114778 cites W2038431330 @default.
- W2497114778 cites W2062069198 @default.
- W2497114778 cites W2069845949 @default.
- W2497114778 cites W2075404238 @default.
- W2497114778 cites W2090973422 @default.
- W2497114778 cites W2094829108 @default.
- W2497114778 cites W2110015307 @default.
- W2497114778 cites W2120656656 @default.
- W2497114778 cites W2123113463 @default.
- W2497114778 cites W2126712477 @default.
- W2497114778 cites W2138784667 @default.
- W2497114778 cites W2139028067 @default.
- W2497114778 cites W2139706862 @default.
- W2497114778 cites W2152114458 @default.
- W2497114778 cites W4210987384 @default.
- W2497114778 cites W874045298 @default.
- W2497114778 doi "https://doi.org/10.5468/ogs.2016.59.4.261" @default.
- W2497114778 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4958671" @default.
- W2497114778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27462592" @default.
- W2497114778 hasPublicationYear "2016" @default.
- W2497114778 type Work @default.
- W2497114778 sameAs 2497114778 @default.
- W2497114778 citedByCount "20" @default.
- W2497114778 countsByYear W24971147782016 @default.
- W2497114778 countsByYear W24971147782017 @default.
- W2497114778 countsByYear W24971147782018 @default.
- W2497114778 countsByYear W24971147782019 @default.
- W2497114778 countsByYear W24971147782020 @default.
- W2497114778 countsByYear W24971147782021 @default.
- W2497114778 countsByYear W24971147782022 @default.
- W2497114778 countsByYear W24971147782023 @default.
- W2497114778 crossrefType "journal-article" @default.
- W2497114778 hasAuthorship W2497114778A5002541135 @default.
- W2497114778 hasAuthorship W2497114778A5021475520 @default.
- W2497114778 hasAuthorship W2497114778A5075968961 @default.
- W2497114778 hasAuthorship W2497114778A5077805782 @default.
- W2497114778 hasAuthorship W2497114778A5079807358 @default.
- W2497114778 hasAuthorship W2497114778A5081845574 @default.
- W2497114778 hasAuthorship W2497114778A5084956582 @default.
- W2497114778 hasBestOaLocation W24971147781 @default.
- W2497114778 hasConcept C10205521 @default.
- W2497114778 hasConcept C104317684 @default.
- W2497114778 hasConcept C121608353 @default.
- W2497114778 hasConcept C126322002 @default.
- W2497114778 hasConcept C136302470 @default.
- W2497114778 hasConcept C145103041 @default.
- W2497114778 hasConcept C1491633281 @default.
- W2497114778 hasConcept C2776839831 @default.
- W2497114778 hasConcept C2777292972 @default.
- W2497114778 hasConcept C2777877089 @default.
- W2497114778 hasConcept C2777933648 @default.
- W2497114778 hasConcept C2780427987 @default.
- W2497114778 hasConcept C2780932548 @default.
- W2497114778 hasConcept C28328180 @default.
- W2497114778 hasConcept C501593827 @default.
- W2497114778 hasConcept C502942594 @default.
- W2497114778 hasConcept C55427017 @default.
- W2497114778 hasConcept C55493867 @default.
- W2497114778 hasConcept C71924100 @default.
- W2497114778 hasConcept C86803240 @default.
- W2497114778 hasConcept C95444343 @default.
- W2497114778 hasConcept C96232424 @default.
- W2497114778 hasConceptScore W2497114778C10205521 @default.
- W2497114778 hasConceptScore W2497114778C104317684 @default.
- W2497114778 hasConceptScore W2497114778C121608353 @default.
- W2497114778 hasConceptScore W2497114778C126322002 @default.
- W2497114778 hasConceptScore W2497114778C136302470 @default.
- W2497114778 hasConceptScore W2497114778C145103041 @default.
- W2497114778 hasConceptScore W2497114778C1491633281 @default.
- W2497114778 hasConceptScore W2497114778C2776839831 @default.
- W2497114778 hasConceptScore W2497114778C2777292972 @default.
- W2497114778 hasConceptScore W2497114778C2777877089 @default.
- W2497114778 hasConceptScore W2497114778C2777933648 @default.
- W2497114778 hasConceptScore W2497114778C2780427987 @default.
- W2497114778 hasConceptScore W2497114778C2780932548 @default.
- W2497114778 hasConceptScore W2497114778C28328180 @default.
- W2497114778 hasConceptScore W2497114778C501593827 @default.
- W2497114778 hasConceptScore W2497114778C502942594 @default.